Sara J Becker1, Daniel D Squires1, David R Strong2, Nancy P Barnett1, Peter M Monti1, Nancy M Petry3. 1. a Center for Alcohol and Addictions Studies , Brown University , Providence , Rhode Island , USA. 2. b Department of Family and Preventive Medicine , University of California San Diego School of Medicine , La Jolla , California , USA. 3. c Department of Medicine , University of Connecticut Health Center , Farmington , Connecticut , USA.
Abstract
BACKGROUND: Few prospective studies have evaluated theory-driven approaches to the implementation of evidence-based opioid treatment. This study compared the effectiveness of an implementation model (Science to Service Laboratory; SSL) to training as usual (TAU) in promoting the adoption of contingency management across a multisite opioid addiction treatment program. We also examined whether the SSL affected putative mediators of contingency management adoption (perceived innovation characteristics and organizational readiness to change). METHODS:Sixty treatment providers (39 SSL, 21 TAU) from 15 geographically diverse satellite clinics (7 SSL, 8 TAU) participated in the 12-month study. Both conditions received didactic contingency management training and those in the predetermined experimental region received 9 months of SSL-enhanced training. Contingency management adoption was monitored biweekly, whereas putative mediators were measured at baseline, 3 months, and 12 months. RESULTS: Relative to providers in the TAU region, treatment providers in the SSL region had comparable likelihood of contingency management adoption in the first 20 weeks of the study, and then significantly higher likelihood of adoption (odds ratios = 2.4-13.5) for the remainder of the study. SSL providers also reported higher levels of one perceived innovation characteristic (Observability) and one aspect of organizational readiness to change (Adequacy of Training Resources), although there was no evidence that the SSL affected these putative mediators over time. CONCLUSIONS: Results of this study indicate that a fully powered randomized trial of the SSL is warranted. Considerations for a future evaluation are discussed.
RCT Entities:
BACKGROUND: Few prospective studies have evaluated theory-driven approaches to the implementation of evidence-based opioid treatment. This study compared the effectiveness of an implementation model (Science to Service Laboratory; SSL) to training as usual (TAU) in promoting the adoption of contingency management across a multisite opioid addiction treatment program. We also examined whether the SSL affected putative mediators of contingency management adoption (perceived innovation characteristics and organizational readiness to change). METHODS: Sixty treatment providers (39 SSL, 21 TAU) from 15 geographically diverse satellite clinics (7 SSL, 8 TAU) participated in the 12-month study. Both conditions received didactic contingency management training and those in the predetermined experimental region received 9 months of SSL-enhanced training. Contingency management adoption was monitored biweekly, whereas putative mediators were measured at baseline, 3 months, and 12 months. RESULTS: Relative to providers in the TAU region, treatment providers in the SSL region had comparable likelihood of contingency management adoption in the first 20 weeks of the study, and then significantly higher likelihood of adoption (odds ratios = 2.4-13.5) for the remainder of the study. SSL providers also reported higher levels of one perceived innovation characteristic (Observability) and one aspect of organizational readiness to change (Adequacy of Training Resources), although there was no evidence that the SSL affected these putative mediators over time. CONCLUSIONS: Results of this study indicate that a fully powered randomized trial of the SSL is warranted. Considerations for a future evaluation are discussed.
Authors: Wilson M Compton; Jack B Stein; Elizabeth B Robertson; Denise Pintello; Beverly Pringle; Nora D Volkow Journal: J Subst Abuse Treat Date: 2005-10
Authors: Bohdan Nosyk; M Douglas Anglin; Suzanne Brissette; Thomas Kerr; David C Marsh; Bruce R Schackman; Evan Wood; Julio S G Montaner Journal: Health Aff (Millwood) Date: 2013-08 Impact factor: 6.301
Authors: Sara J Becker; Lourah M Kelly; Augustine W Kang; Katherine I Escobar; Daniel D Squires Journal: Subst Abus Date: 2018-05-03 Impact factor: 3.716
Authors: Oladunni Oluwoye; Liat Kriegel; Karl C Alcover; Sterling McPherson; Michael G McDonell; John M Roll Journal: Psychol Addict Behav Date: 2019-07-01
Authors: Caroline A Kristunas; Karla Hemming; Helen Eborall; Sandra Eldridge; Laura J Gray Journal: BMC Med Res Methodol Date: 2019-01-10 Impact factor: 4.615
Authors: Sara J Becker; Cara M Murphy; Bryan Hartzler; Carla J Rash; Tim Janssen; Mat Roosa; Lynn M Madden; Bryan R Garner Journal: Addict Sci Clin Pract Date: 2021-10-12
Authors: Cara C Lewis; Meredith R Boyd; Callie Walsh-Bailey; Aaron R Lyon; Rinad Beidas; Brian Mittman; Gregory A Aarons; Bryan J Weiner; David A Chambers Journal: Implement Sci Date: 2020-04-16 Impact factor: 7.327